We are live on ! Find out more
NMTR

9 Meters Biopharma
NMTR

Delisted

NMTR was delisted on the 25th of July, 2023.

Back to rankings

105 hedge funds and large institutions have $94.2M invested in 9 Meters Biopharma in 2021 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 28 increasing their positions, 21 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 11

33% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 21

15% more capital invested

Capital invested by funds: $81.7M → $94.2M (+$12.5M)

6% more funds holding

Funds holding: 99 → 105 (+6)

18% less call options, than puts

Call options by funds: $3.34M | Put options by funds: $4.1M

Holders
105
Holders Change
+6
Holders Change %
+6.06%
% of All Funds
1.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
28
Reduced
21
Closed
11
Calls
$3.34M
Puts
$4.1M
Net Calls
-$757K
Net Calls Change
-$319K

Top Buyers

Rank Fund Capital Flow
1
GTC
Ghost Tree Capital
New York
+$3.24M
2
Northern Trust
Northern Trust
Illinois
+$1.6M
3
N
Nuveen
North Carolina
+$1.03M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$876K
5
State Street
State Street
Massachusetts
+$597K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$2.59M
2
Deutsche Bank
Deutsche Bank
Germany
-$2.46M
3
Two Sigma Advisers
Two Sigma Advisers
New York
-$1.78M
4
Renaissance Technologies
Renaissance Technologies
New York
-$1.44M
5
Morgan Stanley
Morgan Stanley
New York
-$1.28M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIP
76
Ameritas Investment Partners
Nebraska
$22K – – –
Prudential Financial
77
Prudential Financial
New Jersey
$22K +$4.53K +192 +30%
SXL
78
Summit X LLC
Missouri
$21K – – –
KIA
79
KCM Investment Advisors
California
$20K – – –
Brown Advisory
80
Brown Advisory
Maryland
$19K +$17K +722 New
GCP
81
GSA Capital Partners
United Kingdom
$18K +$16.6K +705 New
Squarepoint
82
Squarepoint
New York
$17K -$11.9K -504 -43%
TRCT
83
Tower Research Capital (TRC)
New York
$17K -$10.4K -441 -39%
RJA
84
Raymond James & Associates
Florida
$17K – – –
Mackenzie Financial
85
Mackenzie Financial
Ontario, Canada
$16K +$14.6K +618 New
VF
86
Virtu Financial
New York
$15K -$185K -7,846 -93%
X
87
Xponance
Pennsylvania
$14K -$1.3K -55 -9%
OC
88
Oppenheimer & Co
New York
$14K – – –
XT
89
XTX Topco
Cayman Islands
$13K -$12K -510 -50%
GA
90
Gateway Advisory
New Jersey
$13K – – –
IWM
91
IHT Wealth Management
Illinois
$13K – – –
IFG
92
Independent Financial Group
California
$13K – – –
PAG
93
Private Advisor Group
New Jersey
$13K – – –
SCP
94
Sandhill Capital Partners
New York
$13K – – –
WS
95
Wedbush Securities
California
$13K – – –
CIC
96
Carnegie Investment Counsel
Ohio
$13K +$11.8K +500 New
Wells Fargo
97
Wells Fargo
California
$10K – – –
HI
98
Harbour Investments
Wisconsin
$7K – – –
MA
99
MCF Advisors
Kentucky
$7K – – –
CG
100
Cutler Group
California
$5K – – –
1 2 3
4
5

NMTR Hedge Fund Activity: Q3 2021 in Review

105 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in 9 Meters Biopharma (NMTR) for Q3 2021, worth a combined $94.2M — up 15% from $81.7M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new NMTR positions and 11 closed out — a net gain of 7 holders — while 28 added to existing stakes and 21 trimmed.

The largest buyer was Ghost Tree Capital, opening a new position worth an estimated $3.24M. The largest seller was Millennium Management, cutting an estimated $2.59M.

  • 105 institutional investors held 9 Meters Biopharma (NMTR) as of Q3 2021, up from 99 in Q2 2021.
  • Funds reported $94.2M of 9 Meters Biopharma stock for Q3 2021, up 15% quarter-over-quarter.
  • 18 funds opened new 9 Meters Biopharma positions in Q3 2021 and 11 closed out, a net change of +7 holders.
  • The largest 9 Meters Biopharma buyer in Q3 2021 was Ghost Tree Capital, an estimated $3.24M added.
  • The largest 9 Meters Biopharma seller in Q3 2021 was Millennium Management, an estimated $2.59M sold.

Based on aggregated 13F filings for Q3 2021.